A simulation study to compare three self-controlled case series approaches: Correction for violation of assumption and evaluation of bias

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 8, 2013, Pages 819-825

  Hua, Wei ^a   Sun, Guoying ^a   Dodd, Caitlin N ^b   Romio, Silvana A ^c   Whitaker, Heather J ^d   Izurieta, Hector S ^a   Black, Steven ^b   Sturkenboom, Miriam C J M ^c   Davis, Robert L ^e   Deceuninck, Genevieve ^f   Andrews, N J ^g  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d OPEN UNIVERSITY   (United Kingdom)

^e KAISER PERMANENTE   (United States)

^f University Laval   (Canada)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Assumption; Bias; Guillain Barr syndrome; Influenza vaccine; Pharmacoepidemiology; Self controlled case series; Simulation

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CASE STUDY; DRUG CONTRAINDICATION; DRUG EXPOSURE; EXPOSURE VARIABLE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; METHODOLOGY; PRIORITY JOURNAL; PROBABILITY; SELF CONTROLLED CASE SERIES; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL MODEL; SYSTEMATIC ERROR; TREATMENT OUTCOME;

ASSUMPTION; BIAS; GUILLAIN-BARRÉ SYNDROME; INFLUENZA VACCINE; PHARMACOEPIDEMIOLOGY; SELF-CONTROLLED CASE SERIES; SIMULATION;

BIAS (EPIDEMIOLOGY); COMPUTER SIMULATION; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LIKELIHOOD FUNCTIONS; PHARMACOEPIDEMIOLOGY; PROBABILITY; RESEARCH DESIGN; TIME FACTORS;

EID: 84880752192     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3451     Document Type: Article

References (16)

1. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995; 51: 228-235.
2. Whitaker HJ, Farrington CP, Spiessens B, et al. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006; 25: 1768-1797.
3. Whitaker HJ, Hocine MN, Farrington CP. The methodology of self-controlled case series studies. Stat Methods Med Res 2009; 18: 7-26.
4. Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol 1996; 143: 1165-1173.
5. Weldeselassie YG, Whitaker HJ, Farrington CP. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect 2011; 139: 1805-1817.
6. Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 2009; 10: 3-16.
7. Stowe J, Andrews N, Wise L, et al. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009; 169: 382-388.
8. Grimaldi-Bensouda L, Alperovitch A, Besson G, et al. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011; 174: 326-335.
9. Langmuir AD, Bregman DJ, Kurland LT, et al. An epidemiologic and clinical evaluation of Guillain-Barre syndrome reported in association with the administration of swine influenza vaccines. Am J Epidemiol 1984; 119: 841-879.
10. Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. Am J Epidemiol 1979; 110: 105-123.
11. Burwen DR, Ball R, Bryan WW, et al. Evaluation of Guillain-Barre Syndrome among recipients of influenza vaccine in 2000 and 2001. Am J Prev Med 2010; 39: 296-304.
12. Greene SK, Rett M, Weintraub ES, et al. Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. Am J Epidemiol 2012; 175: 1100-1109.
13. Centers for Disease Control and Prevention. Seasonal Influenza Past Weekly Surveillance Reports. 2013.
14. Institute of Medicine. Influenza Vaccines and Neurological Complications. In Immunization Safety Review, Stratton K, Almario DA, Wizemann T, et al. (eds.). The National Academies Press: Washington DC, 2004.
15. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010; 59: 1-62.
16. Kuhnert R, Hecker H, Poethko-Muller C, et al. A modified self-controlled case series method to examine association between multidose vaccinations and death. Stat Med 2011; 30: 666-677.